This study emphasizes the potential of MSK1 methylation levels and executive function as key indicators in predicting suicidal ideation among adolescents with major depressive disorder, providing a new dimension to our understanding of suicide risk factors in this age group.

Explore the potential of tDCS as a non-pharmacological intervention for Alzheimer’s disease, demonstrating significant cognitive improvements linked to enhanced cortical plasticity, without serious adverse effects.

The TASTE-SL trial presents compelling evidence that Sanbexin, a sublingual combination of edaravone and dexborneol, offers a significant improvement in recovery for acute ischemic stroke patients, marking a notable advancement in neuroprotective treatment strategies.

In the evolving landscape of MS treatment, the strategic choice between early aggressive and escalation therapies is critical. Understanding the nuances of patient-specific factors, such as age and disease activity, can significantly influence outcomes and guide effective management.

Explore the integration of service animals into patient care plans, highlighting their role in enhancing independence and supporting diverse medical needs.

Explore the complexities of cannabis withdrawal, including its symptoms, management strategies, and the role of healthcare providers in supporting patients through this transition.